PharmGen Science, Inc. (KRX:004720)
3,505.00
-325.00 (-8.49%)
Mar 4, 2026, 3:33 PM KST
-19.98% (1Y)
| Market Cap | 76.69B |
| Revenue (ttm) | 171.66B |
| Net Income (ttm) | 117.75M |
| Shares Out | 21.91M |
| EPS (ttm) | 6.50 |
| PE Ratio | 651.33 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 251,423 |
| Average Volume | 98,350 |
| Open | 3,800.00 |
| Previous Close | 3,830.00 |
| Day's Range | 3,450.00 - 3,830.00 |
| 52-Week Range | 3,490.00 - 5,490.00 |
| Beta | 0.32 |
| RSI | 29.59 |
| Earnings Date | Mar 20, 2026 |